NCT06785675 Assessing Short-term Treatment Satisfaction and Quality of Life in Patients With Hidradenitis Suppurativa Initiated on Secukinumab. Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06784752 Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET Status RECRUITING Phase PHASE3
NCT06780670 Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy Status RECRUITING Phase PHASE2/PHASE3
NCT06773936 Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia Status ENROLLING_BY_INVITATION Phase PHASE2
NCT06770543 Leqvio rPMS (Regulatory Post-Marketing Surveillance in Korea) Status RECRUITING Phase N/A
NCT06751238 Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA). Status RECRUITING Phase PHASE1
NCT06744920 A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis Status RECRUITING Phase PHASE3
NCT06737419 Real World Effectiveness, Persistence, Tolerability, and Safety of Ofatumumab in Clinical Practice Status COMPLETED Phase N/A
NCT06733922 ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS Status RECRUITING Phase PHASE4
NCT06726148 Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06715254 A Real-world Study of Tuberculosis Incidence in AS, PsA, or PsO Patients Treated With Secukinumab in Brazil Status TERMINATED Phase N/A
NCT06711887 Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension) Status RECRUITING Phase PHASE3
NCT06704269 Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis Status RECRUITING Phase PHASE1/PHASE2
NCT06699914 A Study to Evaluate Real-world Brolucizumab Effectiveness and Safety in Japanese Patients With Neovascular Age-related Macular Degeneration (nAMD) Status COMPLETED Phase N/A
NCT06692803 Real-World Treatment Patterns and Outcomes Among Patients With Chronic Myeloid Leukemia in Earlier Lines of Therapy Status COMPLETED Phase N/A
NCT06684964 RWE,NIS,Prospective Study for the Effectiveness, Tolerability and Adherence of Asciminib in Saudi Arabia. (ASC4REAL) Status RECRUITING Phase N/A
NCT06683768 A Real-world Study of the Safety of Hypertension Medication Therapy in Japanese Patients With Naïve Hypertension Status COMPLETED Phase N/A
NCT06675864 Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (PMS) Status RECRUITING Phase PHASE1/PHASE2
NCT06669221 Effectiveness of Early Intervention in Transfusion Independent Aplastic Anemia: a Retrospective Medical Claims Database Study Status COMPLETED Phase N/A